Flowcarbon's versatile team merges investment banking, project finance, tax credit and other financial markets expertise to streamline access to creative capital solutions for the world’s most innovative companies in the infrastructure, decarbonization, and other niche sectors. Flowcarbon is headquartered in New York, United States and was founded in 2021.
GeNeuro is a biotechnology company that develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of the human endogenous retroviral origin. The company is primarily focused on nervous system diseases such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody for the treatment of multiple sclerosis. It also develops diagnostic tests to dose the multiple sclerosis-associated retrovirus-ENV proteins in patients.GeNeuro was founded in 2006 and is based in Plan-Les-Ouates, Switzerland.
Copper Banking is a financial education platform designed to empower teenagers with financial literacy and banking services. By offering a user-friendly app and debit card, Copper enables teens to manage their money effectively, gaining hands-on experience that traditional banks often overlook. The platform facilitates money transfers, direct deposits, and payments while fostering a connection between parents and teens regarding financial decisions. Additionally, Copper provides exclusive content crafted by financial literacy experts, equipping users with valuable advice and tips to enhance their understanding of personal finance and help them take control of their financial futures. Through these features, Copper seeks to instill responsible financial habits in young users.
Swiggy is an on-demand food delivery platform that brings food from neighborhood restaurants directly to customers' doors. The company's food delivery platform lists local restaurants and menu lists on an app for users to order from and track the delivery of its delivery executives, enabling users to order food with speed and convenience. Its service is used to pick up and drop off a diverse array of items, including laundry and document or parcel deliveries to business clients and retail customers.
Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.
Pine Labs offers a merchant platform that includes technology and financial solutions for merchants. These solutions are aimed at helping merchants in increasing their revenue and reduce cost, complexity, and risk. The company connects financial institutions and consumer brands to enable merchants to deliver value to their retail customers. It powers offline and online last-mile retail transactions, provides customer insights for targeted sales, and offers financial solutions. The company’s cloud-based platform powers 3,50,000+ POS terminals across 3700 cities and towns in India and Malaysia. Over 1,00,000 merchants across sectors - electronics, food and beverage, fashion, airlines, and more, use Pine Labs’ solutions. 15 major banks, 7 financial institutions, and 100+ brands are part of Pine Labs’ platform.
Aumni is a data-driven investment analytics platform based in the United States, specifically designed for private capital markets, including venture funds, family offices, university endowments, and corporate venture firms. Founded by former corporate attorneys Tony Lewis and Kelsey Chase in Salt Lake City, Aumni utilizes a combination of artificial intelligence and human expertise to extract and analyze critical deal data from complex legal agreements. The platform provides strategic insights related to the economic positions and legal rights of investors by converting intricate deal data into a clear, complete, and accurate dataset. Additionally, Aumni conducts audits and analyses of transactions to ensure the completeness and accuracy of documentation, thereby enabling investors and venture firms to make informed decisions based on a comprehensive understanding of their investments. The company has successfully analyzed a vast array of private capital data, representing investors with over $1 trillion in assets under management.
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Mynd is a technology-driven property management firm that specializes in managing single-family rental properties. The company is dedicated to helping property owners optimize their real estate investments through a comprehensive suite of services, which includes property marketing, tenant screening, rent collection, property maintenance, and accounting. By focusing on the rental sector, Mynd aims to simplify the property management process, reducing the everyday burdens faced by landlords while maximizing their investment returns. The firm leverages technology and data analytics to improve property performance and ensure effective communication with clients. Property owners benefit from access to financial reports and real-time updates, enabling them to make informed decisions about their investments through Mynd's digital platforms.
Brii Biosciences Limited is a biotechnology company focused on the research, development, and commercialization of medicines for chronic illnesses, particularly infectious diseases, liver, and lung conditions. Founded in 2018, the company operates from Durham, North Carolina, with additional offices in Shanghai, Beijing, and San Francisco. Brii Biosciences aims to provide innovative biopharmaceutical solutions tailored to the needs of Chinese patients, addressing public health challenges such as hepatitis B, HIV, and multidrug-resistant infections. The company leverages technology and data to enhance the Chinese healthcare system, ensuring better access to effective treatments. With a diverse pipeline of over ten product candidates, Brii Biosciences is committed to improving health outcomes for patients suffering from both infectious and central nervous system diseases.
Godrej Properties brings the Godrej Group philosophy of innovation and excellence to the real estate industry. Each Godrej Properties development combines a 119-year legacy of excellence and trust with a commitment to cutting-edge design and technology. Godrej Properties is currently developing residential, commercial and township projects spread across 10.3 million square meters (111 million square feet) in 12 cities.
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.
Expert.ai is a developer of enterprise natural language processing (NLP) technologies that focuses on transforming language-intensive processes into actionable insights. The company's platform combines symbolic human-like comprehension with machine learning, enabling organizations to enhance decision-making across various sectors, including insurance, banking, publishing, defense, and life sciences. Key offerings include Cogito Discover, a software that utilizes artificial intelligence for analytics, extraction, and categorization of text from various formats, and the Clinical Research Navigator, which assists biomedical clients in researching therapies for infectious diseases. Expert.ai provides its solutions through on-premise, private, and public cloud options, facilitating the adoption of AI technologies and streamlining data science capabilities for a diverse range of industries.
Clarksons offers its diverse and growing client base an unrivalled range of shipbroking services, sector research, on-hand logistical support and full investment banking capabilities in all key shipping and offshore sectors.
Intelliflo redblack is a developer of intuitive software designed to support registered investment advisors (RIAs) and family offices in managing their trading and rebalancing needs. The platform offers a comprehensive solution that includes portfolio monitoring, pre-trade and post-trade compliance, and order management, all within a single, scalable system. This capability allows firms to enhance client value while achieving growth and operational efficiency. By integrating seamlessly with existing technology infrastructures, intelliflo redblack empowers advisors to deliver personalized services with superior precision, ultimately helping them navigate the complexities of investment management more effectively.
Grab operates a mobile technology platform that integrates city transportation for driver-partners and customers in South East Asia. It offers services like GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. Grab offers services in Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Anthony Tan and Tan Hooi Lng founded it in 2012 and is headquartered in Singapore. It has additional offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam.
Evofem Biosciences is a biopharmaceutical company focused on women's sexual and reproductive health. The company has developed Phexxi, a hormone-free vaginal gel that is the first of its kind approved in the United States for the prevention of pregnancy. Additionally, Evofem is working on EVO100, a vaginal pH regulator designed to prevent the transmission of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. Headquartered in San Diego, California, Evofem aims to address unmet needs in the field of women’s health through innovative products.
They are dedicated to serving the needs of our clients, who range from financial advisors and individual investors to corporations and endowments.
IntelliFlo Ltd. is a provider of web-based business management software tailored for the financial services industry in the United Kingdom. Founded in 2004 and based in Kingston-upon-Thames, the company offers its flagship product, Intelligent Office, which serves various financial professionals including advisers, mortgage advisers, and service providers. Intelligent Office features a comprehensive suite of tools for client management, financial planning, document management, compliance, and workflow, alongside integrated solutions like FE Analytics for investment research and portfolio monitoring. Supporting over 30,000 financial professionals globally, IntelliFlo aims to simplify complex digital processes and enhance operational efficiency, ultimately facilitating better access to financial advice. The company continuously evolves its offerings to meet the dynamic needs of its clients and their customers.
Alfred Club, Inc. is a technology-driven company that provides a resident experience and building management platform designed for apartment buildings. Founded in 2013 and based in New York, Alfred offers the Hello Alfred program, which allows residents to outsource everyday tasks such as package receiving and dog walking to dedicated home managers. These home managers are W-2 employees, ensuring they receive benefits and training, which enhances service quality and fosters local community support. The platform integrates various services, enabling residents to request assistance with grocery delivery, home cleaning, and access to exclusive events and virtual classes, all through a single, intuitive interface. Alfred has been recognized as a leader in transforming the real estate industry and has gained media attention for its innovative approach to enhancing the residential living experience.
T She Dingzhi offers a platform for clothes design. Their business enables additional, fully-customizable t-shirts, hoodies, and sweaters to its clients. Through responsible, managed services, subscription cultural apparel, and other means, they are dedicated to assisting businesses in improving their services. It adapts and pursues accuracy and exquisite, repeatedly setting the bar for the sector.
Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, focused on developing and commercializing medical devices and pharmaceuticals that leverage mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic product designed to replicate the functions of lamellar bodies, primarily targeting respiratory diseases such as cystic fibrosis, as well as conditions like dry eye disease and radiotherapy-induced xerostomia. Established in June 2007, Lamellar Biomedical acquired the intellectual property rights to this innovative technology, which aims to improve treatment outcomes through anti-infective properties that enhance antibiotic efficacy and facilitate the delivery of genetic material for pulmonary disease therapies. The company's efforts are directed towards providing transformative solutions for complex and rare respiratory conditions.
Source is uniquely positioned to deliver highly liquid products that respond to the challenges and opportunities of the market They partner with some of the world’s largest investment houses and asset managers to create products that either offer exposure to new opportunities in the market or deliver existing strategies more effectively. They work together to ensure all of their products are efficient and transparent. On top of this, they work closely with some of the most well respected trading houses in Europe to ensure that their products are also priced as fairly as possible and are tradable throughout the day. Source is a global investment firm and one of the fastest growing European providers of exchange traded products (ETPs) By focusing on the ever-evolving needs of investors, they have grown assets under management to more than $19 billion (as at 30 July 2014) since their launch in April 2009, and during this time investors have traded more than $575 billion of Source’s products. They offer investors an efficient and transparent way to invest in equities, fixed income and commodities, as well as some alternative asset classes. Their ETPs are open-ended and domiciled in Dublin.
Glide Pharmaceutical Technologies is a clinical stage development company that specializes in the creation of solid dose formulations for therapeutics and vaccines. The company is known for its innovative solid dose injector system, which aims to enhance patient compliance in self-administering long-term therapies. Glide's product pipeline features formulations for various medications, including octreotide, teriparatide, and vaccines for anthrax and influenza. The company's focus on needle-free injection methods seeks to improve the treatment experience for both patients and healthcare providers. Formerly known as Caretek Medical, Glide Pharmaceutical is dedicated to advancing healthcare through its unique delivery systems.
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.
Private Equity Round in 2016
Nexeon Limited is a developer and manufacturer of advanced silicon-based anode materials for rechargeable lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, the company focuses on creating innovative battery materials that enhance energy density and capacity. These improvements allow for the production of lighter, more powerful batteries that can support a variety of applications, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense industries. By enabling longer battery life and faster charging times, Nexeon's technology plays a crucial role in advancing sustainable energy solutions and supporting the transition to a net-zero environment. The company boasts a skilled technical team with diverse expertise to drive its research and development efforts.
Jemstep is transforming the way investment advisors run their businesses through an automated client engagement, onboarding and service platform. With Jemstep Advisor Pro, advisors can attract more prospects, increase AUM, and service clients more efficiently. Jemstep award-winning advisor platform provides powerful client engagement and onboarding capabilities while integrating on the back-end with best of breed service providers such as Veo, Salesforce, Orion, Fiserv and others to provide RIAs, BD's and advisors with a complete and customizable business system that augments their value proposition.
Private Equity Round in 2015
Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. <a href="http://www.gelesis.com/">Gelesis</a> was founded in 2006 in Boston, Massachusetts
Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, focused on developing and commercializing medical devices and pharmaceuticals that leverage mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic product designed to replicate the functions of lamellar bodies, primarily targeting respiratory diseases such as cystic fibrosis, as well as conditions like dry eye disease and radiotherapy-induced xerostomia. Established in June 2007, Lamellar Biomedical acquired the intellectual property rights to this innovative technology, which aims to improve treatment outcomes through anti-infective properties that enhance antibiotic efficacy and facilitate the delivery of genetic material for pulmonary disease therapies. The company's efforts are directed towards providing transformative solutions for complex and rare respiratory conditions.
Private Equity Round in 2015
Mereo Biopharma, based in London and founded in 2015, focuses on developing innovative therapeutics for rare diseases and cancer. The company addresses the challenges pharmaceutical firms face in advancing their drug development programs, particularly those with limited resources and extensive pipelines. Mereo has acquired a mid-late stage portfolio of three well-characterized products from Novartis Pharmaceuticals, each supported by comprehensive pre-clinical and proof-of-concept data. The company's mission is to transform the lives of patients with significant unmet medical needs by progressing these products through critical development stages. Mereo leverages its expertise in product selection and value creation, complemented by a partnership with a leading global contract research organization, ICON. This collaboration allows Mereo to maintain operational efficiency while accessing the financial resources necessary for comprehensive clinical studies. The company aims to either partner or divest its products after reaching key value inflection points, with the option to directly commercialize therapies, particularly for orphan diseases.
Akamis Bio is a clinical-stage oncology company dedicated to improving the lives of cancer patients through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company is focused on developing a range of therapeutics aimed at solid tumors, utilizing its proprietary T-SIGn virus platform administered intravenously. This approach aims to enhance the ability of a patient's immune system to identify, attack, and eliminate cancer cells, providing a targeted treatment option for those affected by cancer.
SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.
Luminex Trading & Analytics is a creator of an equity trading platform designed to provide access to clean, natural block liquidity at significantly lower trading costs. They're interacting only with venue-approved participants, the platform provides low-cost trading with minimal information leakage, allowing traders to execute large block trades with less market impact.
Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs manufactures and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9. Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.
Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.
Kuur Therapeutics Limited specializes in the development and commercialization of CAR-NKT cell immunotherapies aimed at treating various forms of cancer. The company has established a pipeline of innovative immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics focuses on creating off-the-shelf engineered CAR-NKT cell therapies, harnessing the unique capabilities of natural killer T cells combined with advanced CAR construct engineering. This approach aims to provide effective treatments for both solid and hematological tumors, thereby enhancing patient care. Established in 2005 and based in London, the company was previously known as Cell Medica Limited before rebranding in February 2020. Kuur Therapeutics is actively engaged in clinical trials to advance its CAR-NKT cell therapies.
Private Equity Round in 2014
Generator Hostel owns and operates a network of hostels across Europe and the United States, catering to a diverse range of travelers. The company offers various accommodation options, including shared dormitories and private en-suite rooms, ensuring flexibility for different preferences and budgets. In addition to sleeping arrangements, Generator Hostel features communal areas for relaxation, as well as bars and cafes that enhance the guest experience. The focus on providing comfortable and social environments makes Generator Hostel a popular choice among travelers seeking both affordability and quality in their lodging.
Alkermes, Inc. is an integrated biotechnology company focused on developing, manufacturing, and commercializing medicines for chronic diseases. The company offers VIVITROL, an extended-release injectable medication for alcohol dependence, and manufactures RISPERDAL CONSTA, used to treat schizophrenia and bipolar I disorder. Alkermes also has a diverse pipeline that includes extended-release injectable and oral products targeting various conditions, including central nervous system disorders, addiction, diabetes, and autoimmune disorders. With research facilities in Massachusetts and commercial manufacturing operations in Ohio, Alkermes leverages its proprietary technologies and partnerships to address unmet medical needs and improve patient outcomes in therapeutic areas. The company primarily generates revenue in the U.S., with additional operations in Ireland and other international markets.
Ensurge Micropower specializes in the development of ultrathin, flexible, and safe energy storage solutions primarily for wearable devices and connected sensors. The company is known for its innovative solid-state lithium battery technology, which allows for the production of powerful, lightweight, and cost-effective rechargeable batteries suitable for a variety of applications. Ensurge operates a state-of-the-art flexible electronics manufacturing facility in Silicon Valley, where it leverages patented process technology and materials innovation alongside roll-to-roll production methods. This combination enables the company to effectively bring the benefits of its solid-state lithium battery technology to both established and emerging markets. Ensurge has corporate headquarters in Oslo, Norway, and a global headquarters in San Jose, California.
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
infirst HEALTHCARE is a new consumer healthcare company focused on improving well established drugs with IP protected solutions for the OTC/Primary care markets which can be launched within 12-36 months. infirst is a spin-out from SEEK, a UK privately-owned drug discovery group which uses its intellectual property to create breakthrough medicines addressing major diseases, bringing radical improvements to human health. infirst is led by CEO, Manfred Scheske, who was previously President of GSK's US$3 billion European Consumer Healthcare business (including brands such as alli, Aquafresh, Beechams, Corsodyl, Lucozade, Niquitin, Panadol. Piriton, Poligrip, Ribena, Sensodyne, Solpadeine, Zantac and Zovirax) from 2004 to 2010 and also spent six years as President of GSK's Consumer Healthcare business in North America
Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.
Glide Pharmaceutical Technologies is a clinical stage development company that specializes in the creation of solid dose formulations for therapeutics and vaccines. The company is known for its innovative solid dose injector system, which aims to enhance patient compliance in self-administering long-term therapies. Glide's product pipeline features formulations for various medications, including octreotide, teriparatide, and vaccines for anthrax and influenza. The company's focus on needle-free injection methods seeks to improve the treatment experience for both patients and healthcare providers. Formerly known as Caretek Medical, Glide Pharmaceutical is dedicated to advancing healthcare through its unique delivery systems.
Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, focused on developing and commercializing medical devices and pharmaceuticals that leverage mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic product designed to replicate the functions of lamellar bodies, primarily targeting respiratory diseases such as cystic fibrosis, as well as conditions like dry eye disease and radiotherapy-induced xerostomia. Established in June 2007, Lamellar Biomedical acquired the intellectual property rights to this innovative technology, which aims to improve treatment outcomes through anti-infective properties that enhance antibiotic efficacy and facilitate the delivery of genetic material for pulmonary disease therapies. The company's efforts are directed towards providing transformative solutions for complex and rare respiratory conditions.
Kuur Therapeutics Limited specializes in the development and commercialization of CAR-NKT cell immunotherapies aimed at treating various forms of cancer. The company has established a pipeline of innovative immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics focuses on creating off-the-shelf engineered CAR-NKT cell therapies, harnessing the unique capabilities of natural killer T cells combined with advanced CAR construct engineering. This approach aims to provide effective treatments for both solid and hematological tumors, thereby enhancing patient care. Established in 2005 and based in London, the company was previously known as Cell Medica Limited before rebranding in February 2020. Kuur Therapeutics is actively engaged in clinical trials to advance its CAR-NKT cell therapies.
Akamis Bio is a clinical-stage oncology company dedicated to improving the lives of cancer patients through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company is focused on developing a range of therapeutics aimed at solid tumors, utilizing its proprietary T-SIGn virus platform administered intravenously. This approach aims to enhance the ability of a patient's immune system to identify, attack, and eliminate cancer cells, providing a targeted treatment option for those affected by cancer.
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.
Spin Memory, Inc. specializes in the development of spin-transfer torque magnetoresistive random access memory (STT-MRAM) technologies and products. Founded in 2007 and headquartered in Fremont, California, the company aims to address the scaling and power challenges faced by memory devices. By providing solutions that replace on-chip SRAM and various non-volatile memories in both embedded and stand-alone applications, Spin Memory enhances speed, power efficiency, and endurance. The underlying technology, known as orthogonal spin transfer MRAM, was initially developed through a collaboration between Allied Minds and New York University, with significant contributions from Professor Andrew Kent. Spin Memory's innovations lead to faster switching times and lower power consumption, without the endurance and data retention limitations found in other implementations of STT-MRAM.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
Nexeon Limited is a developer and manufacturer of advanced silicon-based anode materials for rechargeable lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, the company focuses on creating innovative battery materials that enhance energy density and capacity. These improvements allow for the production of lighter, more powerful batteries that can support a variety of applications, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense industries. By enabling longer battery life and faster charging times, Nexeon's technology plays a crucial role in advancing sustainable energy solutions and supporting the transition to a net-zero environment. The company boasts a skilled technical team with diverse expertise to drive its research and development efforts.
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
MaxWest Environmental Systems develops a system with a gasification and heat integration process that converts biosolids into energy.
Akamis Bio is a clinical-stage oncology company dedicated to improving the lives of cancer patients through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company is focused on developing a range of therapeutics aimed at solid tumors, utilizing its proprietary T-SIGn virus platform administered intravenously. This approach aims to enhance the ability of a patient's immune system to identify, attack, and eliminate cancer cells, providing a targeted treatment option for those affected by cancer.
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.
BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.
LogLogic is the provider of industry's only scalable log and security intelligence platform for the enterprise and cloud. LogLogic, with over 1300 customers, provides solutions that allow customers to collect and analyze terabytes of big data generated by their IT assets and gives Security, IT Ops, and Compliance professionals actionable information at their finger tips to identify issues proactively and make insightful decisions, and also get compliant with various regulations. Currently, LogLogic customers are leveraging its solutions to manage over 1,000 Petabytes (or 1 Exabyte) of data.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
NovaSys Health is a prominent provider of managed healthcare services, operating one of the largest health plans in Arkansas. With approximately 11,000 contracted providers in the region and over 4,300 in Arkansas, the company emphasizes strong relationships with healthcare providers. It offers a range of health plans and related services, including customized solutions, provider relations, and eligibility and billing administration, catering to a diverse network of hospitals, physicians, and ancillary providers.
$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.
Touchdown Technologies, Inc. designs, manufactures, and supports MEMS probecards. The company offers ACCU-TORQ probe, a torsional contactor; and GIGA-TORQ probecards for DRAM applications. Its products support the production wafer test needs of semiconductor manufacturers. Touchdown Technologies, Inc. was formerly known as Integrated Micromachines, Inc. The company was founded in 2003 and is based in Baldwin Park, California.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.
Private Equity Round in 2008
POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques
BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
AccountNow is a prominent provider of prepaid card financial solutions aimed at the approximately 40 million consumers in the United States who lack traditional banking relationships or established credit. The company offers alternatives to conventional checking accounts, facilitating access to essential financial services, including prepaid Visa and MasterCard cards, online bill payment, and card-to-card transfers. AccountNow's services enable users to directly deposit paychecks, shop wherever Visa debit or MasterCard is accepted, and access cash through ATMs globally. Additionally, the accounts come with FDIC-insured deposits, enhancing the security of consumer funds. Prepaid cards are issued by The Bancorp Bank or MetaBank under a license from Visa or MasterCard.
Antenova Ltd specializes in the design, development, and supply of standard and custom antennas, as well as radio frequency antenna modules for a variety of applications. The company's products cater to the wireless machine-to-machine (M2M) and Internet of Things (IoT) sectors, along with consumer electronic devices. Antenova's offerings include specialized antennas for WLAN, Wi-Fi, GPS, and telecom applications, and encompass various product lines such as gigaNOVA, RADIONOVA, and ceriiANT. The company also provides integration services, antenna matching and testing, and custom antenna design alongside sales and technical support. Antenova's solutions are utilized across diverse sectors, including automotive, healthcare, wearables, industrial, and smart city technologies. Established in 1999, the company is headquartered in Hatfield, United Kingdom, with design and sales centers in Taipei, Chicago, and Shanghai, and manufacturing operations in Taiwan and China. Its products are distributed through a global network of distributors.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.
Cortina Systems is a prominent provider of intelligent communication solutions, specializing in advanced port processing and connectivity for various market segments, including Core, Metro, Access, and Enterprise. The company offers a diverse range of products that cater to the performance, density, and flexibility requirements of its customers, enabling faster time-to-market and enhancing revenue opportunities. Through state-of-the-art high-speed analog-digital integration, Cortina Systems focuses on delivering effective network connectivity and bandwidth solutions from core networks to home networks. By closely collaborating with its customers to understand their system requirements, the company positions itself to anticipate future needs and contribute to the development of new generations of communication services.
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
Private Equity Round in 2006
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, focused on developing therapeutics for neurological disorders. The company's clinical pipeline includes several product candidates aimed at treating epilepsy, such as XEN496 and XEN1101, both Kv7 potassium channel modulators currently in Phase II trials, and XEN901, a selective Nav1.6 sodium channel inhibitor in Phase I trials. Additionally, Xenon is developing XEN007, a central nervous system-acting calcium channel modulator, also in Phase I trials. The company leverages insights from genetic research, particularly from families with severe phenotypes, to identify drug targets, which may extend beyond rare genetic disorders. Furthermore, Xenon has established a collaboration with Neurocrine Biosciences to advance the development of innovative epilepsy treatments.
Touchdown Technologies, Inc. designs, manufactures, and supports MEMS probecards. The company offers ACCU-TORQ probe, a torsional contactor; and GIGA-TORQ probecards for DRAM applications. Its products support the production wafer test needs of semiconductor manufacturers. Touchdown Technologies, Inc. was formerly known as Integrated Micromachines, Inc. The company was founded in 2003 and is based in Baldwin Park, California.
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.
Cortina Systems is a prominent provider of intelligent communication solutions, specializing in advanced port processing and connectivity for various market segments, including Core, Metro, Access, and Enterprise. The company offers a diverse range of products that cater to the performance, density, and flexibility requirements of its customers, enabling faster time-to-market and enhancing revenue opportunities. Through state-of-the-art high-speed analog-digital integration, Cortina Systems focuses on delivering effective network connectivity and bandwidth solutions from core networks to home networks. By closely collaborating with its customers to understand their system requirements, the company positions itself to anticipate future needs and contribute to the development of new generations of communication services.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
SkyPilot Networks is a prominent provider of broadband wireless equipment designed for service providers, municipalities, and public safety agencies to efficiently deploy various network services. These services include last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. The company's innovative solution employs a patented multi-hop point-to-multipoint architecture that enhances reach, reduces interference, and optimizes spectral efficiency. This technology results in a scalable, reliable, and deterministic broadband wireless network that simplifies design, increases deployment flexibility, and lowers both equipment and operational costs. SkyPilot's products include the SkyPilot Connector Mini and Pro, which offer cost-effective customer premises equipment for long-range connectivity, and the SkyPilot EMS, an element management system that aids in the deployment and management of wireless mesh networks. With a proven track record, SkyPilot has delivered its systems to customers in over 50 countries and is headquartered in Santa Clara, California.
Arcot Systems, Inc. specializes in authentication and digital signing solutions aimed at protecting and verifying the digital identities of cardholders and merchants. Founded in 1997 and headquartered in Sunnyvale, California, with a technology center in Bangalore, India, the company offers a variety of services, including consumer portal protection, FFIEC compliance, identity management, Internet threat protection, SAFE biopharmaceutical compliance, and VPN authentication. Its key products include TransFort for Issuers and Merchants, RiskFort for real-time fraud prevention, WebFort and ArcotID for software-based authentication, A-OK On-Demand for secure authentication processes, and SignFort to streamline document signing and approval. Arcot Systems serves financial institutions, pharmaceutical companies, and e-commerce platforms, helping them combat online fraud and identity theft.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
GENBAND is a global supplier of IP gateways, session border controllers and FMC security solutions. These high-performance, high-security gateway solutions are at the center of fixed and mobile networks around the globe, evolving, securing and improving communications networks.
WhereNet Corporation specializes in wireless solutions for tracking and managing enterprise assets. The company offers an integrated wireless infrastructure that supports real-time location, messaging, and telemetry applications. Key products include WhereLAN, a cellular network of locating access points; WhereTag, a line of low-powered active radio frequency transmitters; and WhereCall, a wireless messaging system for parts replenishment in industrial manufacturing. Additionally, WhereNet provides software development tools through its Visibility Software Server, facilitating integration with customer and third-party applications. Founded in 1997 and headquartered in Santa Clara, California, WhereNet operates as a subsidiary of Zebra Technologies Corp. The company's solutions are designed to help customers improve operational efficiency, enhance asset returns, and reduce costs, ultimately leading to better customer service.
$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.
Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.
SkyPilot Networks is a prominent provider of broadband wireless equipment designed for service providers, municipalities, and public safety agencies to efficiently deploy various network services. These services include last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. The company's innovative solution employs a patented multi-hop point-to-multipoint architecture that enhances reach, reduces interference, and optimizes spectral efficiency. This technology results in a scalable, reliable, and deterministic broadband wireless network that simplifies design, increases deployment flexibility, and lowers both equipment and operational costs. SkyPilot's products include the SkyPilot Connector Mini and Pro, which offer cost-effective customer premises equipment for long-range connectivity, and the SkyPilot EMS, an element management system that aids in the deployment and management of wireless mesh networks. With a proven track record, SkyPilot has delivered its systems to customers in over 50 countries and is headquartered in Santa Clara, California.
StarVox products are sold and serviced through major solution providers such as Hewlett Packard as a complete, factory-integrated IP telephony solution for service providers. The HP/StarVox Next Generation Telephony Solution combines StarVox software with HP's Open Call Multi Controller application platforms and Cisco Powered Network equipment, making it a carrier-grade, industry-standard solution that will allow a full range of value-added services and upgrades
2Wire is a San Jose, Calif. provider of broadband service products for companies serving consumers.2Wire is dedicated to developing integrated solutions to deliver broadband service and content throughout the home or small office. Built upon the company's core expertise and continued innovation in software and hardware, 2Wire products enable home and small business users to fully leverage the benefits of broadband. In addition, 2Wire solutions offer service providers with a flexible platform to deliver and manage feature-rich Internet, telephony, entertainment, and other enhanced broadband application services
GENBAND is a global supplier of IP gateways, session border controllers and FMC security solutions. These high-performance, high-security gateway solutions are at the center of fixed and mobile networks around the globe, evolving, securing and improving communications networks.
Ishoni Networks develops broadband engines for residential and business customers.
EndPoints is a news organization focused on the biotechnology, pharmaceutical, and life sciences sectors. It provides comprehensive coverage of topics including drug development, clinical trials, regulatory matters, and industry trends. The platform features in-depth articles, breaking news updates, and expert insights to keep industry professionals informed about key developments in the biopharma sector. Additionally, EndPoints produces original editorials that discuss business deals, corporate reorganizations, FDA actions, and the latest clinical data. By delivering timely and accurate information, EndPoints aims to support professionals navigating the rapidly evolving landscape of biotechnology and pharmaceuticals.
Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.